Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Philadelphia | 362 Studies

Clinical Trials Prostate CancerPhiladelphia

Prostate Cancer Clinical Trials in Philadelphia

Find 362 clinical trials for prostate cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 362 trials

CompletedRadiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002874·Birmingham, Alabama and 239 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

CompletedIntimacy-Enhancing Couples' Intervention for Localized Prostate CancerRATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.NCT01982058·New Brunswick, New Jersey and 5 others

Active not recruitingAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryThis randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy and radiation therapy…NCT03070886·Mobile, Alabama and 312 others

RecruitingA Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsThe goal of this clinical trial is to test a new medicine called GSK5764227, which delivers a toxin directly to cancer cells to destroy them while sparing healthy cells.NCT07277270·Reunion, Florida and 21 others

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerThis phase II trial studies how well giving bicalutamide with or without Akt inhibitor MK2206 works in treating patients with previously treated prostate cancer.NCT01251861·Palo Alto, California and 197 others

TerminatedDocetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00786682·Hamilton, New Jersey and 6 others

CompletedPemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate CancerDocetaxel-based therapy has been shown to prolong survival as first-line therapy for patients with hormone refractory prostate cancer (HRPC), and has become the standard of care.NCT00216099·Galesburg, Illinois and 14 others

CompletedADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)A Phase 1/2 multicenter, dose determining, open-label study of ADXS31-142 monotherapy and a combination of ADXS31-142 and pembrolizumab (MK-3475) in participants with metastatic…NCT02325557·San Francisco, California and 7 others

CompletedCopper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSAThis pilot phase I trial studies how well copper Cu 64 TP3805 positron emission tomography (PET) works in detecting prostate cancer in patients with persistently elevated prostate…NCT02989623·Philadelphia, Pennsylvania

Active not recruitingStudy on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to evaluate the efficacy and safety (including evaluating side effects) of combination of olaparib and abiraterone versus placebo and abiraterone in…NCT03732820·Birmingham, Alabama and 131 others

CompletedI-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).This clinical trial was done to show whether a radioactive drug (I-131-1095) that binds to prostate-specific membrane antigen (PSMA) is useful in treating metastatic prostate…NCT03939689·Duarte, California and 26 others

Active not recruitingAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelThis randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with…NCT03419234·Fairbanks, Alaska and 671 others

CompletedVaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerBackground: * Flutamide is an approved drug for prostate cancer that blocks the effects of testosterone on prostate cancer cells and may slow the progression of the disease.NCT00450463·Bethesda, Maryland and 2 others

CompletedSamarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate CancerThe purpose of this study is to determine the safety and effectiveness of Samarium-153 when given in combination with hormonal and external beam radiation therapy in men with high…NCT00328614·Philadelphia, Pennsylvania

CompletedStudy of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)To test the efficacy of CP-751,871 combined with docetaxel and prednisone in the treatment of prostate cancer that is refractory to hormone therapyNCT00313781·Los Angeles, California and 17 others

CompletedThe Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyThe purpose of this study is to compare the effect of an investigational drug used intravenously and placebo administered every three months for one year, on bone loss associated…NCT00063609·Birmingham, Alabama and 43 others

CompletedA Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.This is a study in participants with advanced breast, ovarian, or prostate cancer to investigate the dose, safety, pharmacokinetics, and preliminary efficacy of ipatasertib in…NCT03840200·San Marcos, California and 16 others

CompletedEpoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerRATIONALE: Epoetin alfa may stimulate red blood cell production and may help improve cancer-related anemia and fatigue.NCT00060398·Modesto, California and 139 others

PreviousPage 2 of 19Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma